BCRX icon

BioCryst Pharmaceuticals

91 hedge funds and large institutions have $739M invested in BioCryst Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-11
Holders Change %
-10.78%
% of All Funds
2.43%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
17
Increased
32
Reduced
24
Closed
26
Calls
$5.83M
Puts
$4.63M
Net Calls
+$1.2M
Net Calls Change
+$789K
Name Holding Trade Value Shares
Change
Shares
Change %
JPMorgan Chase & Co
101
JPMorgan Chase & Co
New York
-$357K -36,520 Closed
HCM
102
Highbridge Capital Management
New York
-$321K -32,797 Closed
SCM
103
Stevens Capital Management
Pennsylvania
-$252K -25,754 Closed
Jane Street
104
Jane Street
New York
-$167K -17,114 Closed
T. Rowe Price Associates
105
T. Rowe Price Associates
Maryland
-$167K -17,033 Closed
Group One Trading
106
Group One Trading
Illinois
-$147K -15,064 Closed
CAM
107
ClariVest Asset Management
California
-$147K -15,000 Closed
PPA
108
Parametric Portfolio Associates
Washington
-$146K -14,960 Closed
CA
109
Corrado Advisors
New Jersey
-$144K -14,750 Closed
HighTower Advisors
110
HighTower Advisors
Illinois
-$127K -13,000 Closed
Neuberger Berman Group
111
Neuberger Berman Group
New York
-$112K -11,521 Closed
NI
112
Numeric Investors
Massachusetts
-$106K -10,800 Closed
PM
113
Parametrica Management
Hong Kong
-$98K -10,003 Closed
WA
114
Waverly Advisors
Alabama
-$98K -10,000 Closed
WAM
115
Wolverine Asset Management
Illinois
-$59K -6,050 Closed
QT
116
Quantbot Technologies
New York
-$54K -5,527 Closed
BNP Paribas Financial Markets
117
BNP Paribas Financial Markets
France
-$41K -4,191 Closed